SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001038133-20-000081
Filing Date
2020-11-05
Accepted
2020-11-05 16:50:46
Documents
91
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hska-20200930.htm   iXBRL 10-Q 1974561
2 EX-10.1 heska-09302020xex10x1.htm EX-10.1 140476
3 EX-31.1 heska-09302020xex31x1.htm EX-31.1 11030
4 EX-31.2 heska-09302020xexx31x2.htm EX-31.2 10969
5 EX-32.1 heska-09302020xex32x1.htm EX-32.1 9587
11 LOGO hska-20200930_g1.jpg GRAPHIC 53004
  Complete submission text file 0001038133-20-000081.txt   9755806

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20200930.xsd EX-101.SCH 58394
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20200930_cal.xml EX-101.CAL 153497
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20200930_def.xml EX-101.DEF 346686
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20200930_lab.xml EX-101.LAB 781583
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20200930_pre.xml EX-101.PRE 533819
12 EXTRACTED XBRL INSTANCE DOCUMENT hska-20200930_htm.xml XML 1728039
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22427 | Film No.: 201291277
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences